{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T01:37:05Z","timestamp":1788745025722,"version":"build-2803163510"},"reference-count":24,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2009,10,2]],"date-time":"2009-10-02T00:00:00Z","timestamp":1254441600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0007302","type":"journal-article","created":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T21:19:33Z","timestamp":1254431973000},"page":"e7302","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":74,"title":["Randomized Controlled Trial of RTS,S\/AS02D and RTS,S\/AS01E Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children"],"prefix":"10.1371","volume":"4","clinical-trial-number":[{"clinical-trial-number":"nct00360230","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Seth","family":"Owusu-Agyei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ansong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwaku","family":"Asante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Kwarteng Owusu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Owusu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naana Ayiwa","family":"Wireko Brobby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dosoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Osei Akoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kingsley","family":"Osei-Kwakye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel Asafo","family":"Adjei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwadwo Owusu","family":"Boahen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justice","family":"Sylverken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Adjei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sambian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Apanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kingsley","family":"Kayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Vekemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Opokua","family":"Ofori-Anyinam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Leach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Lievens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Ange","family":"Demoitie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claude","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Ripley","family":"Ballou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Savarese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Chandramohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Owusu","family":"Gyapong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Milligan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sampson","family":"Antwi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsiri","family":"Agbenyega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Greenwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2009,10,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"iv","DOI":"10.4269\/ajtmh.2001.64.iv","article-title":"Introduction and Summary. The intolerable burden of malaria: a new look at the numbers.","volume":"64 (1, 2) S","author":"JG Breman","year":"2001","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1126\/science.1077900","article-title":"A new global effort to control malaria.","volume":"298(5591)","author":"JD Sachs","year":"2002","journal-title":"Science"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"6483","DOI":"10.1016\/j.vaccine.2006.06.033","article-title":"Pre-clinical evaluation of new adjuvant formulations to improve the immunogenicity of the malaria vaccine RTS,S\/AS02A.","volume":"24(42\u201343)","author":"VA Stewart","year":"2006","journal-title":"Vaccine"},{"key":"ref4","article-title":"Malaria-027 trial results.","author":"KE Kester","year":"2005"},{"key":"ref5","article-title":"MAL 044 phase IIb clinical trial comparing two GSK adjuvant formulations AS01B and AS02A at the Walter Reed Project, Kisumu, Kenya.","author":"ME Polhemus","year":"2006"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0140-6736(05)67669-6","article-title":"Duration of protection with RTS,S\/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial.","volume":"366","author":"PL Alonso","year":"2005","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1745-6215-8-11","article-title":"Evaluation of two formulations of adjuvanted RTS, S malaria vaccine in children aged 3 to 5 years living in a malaria-endemic region of Mozambique: a Phase I\/IIb randomized double-blind bridging trial.","volume":"8","author":"EV Macete","year":"2007","journal-title":"Trials"},{"key":"ref8","article-title":"A randomized, observer-blind trial to compare safety and immunogenicity of two adjuvanted RTS,S anti-malaria vaccine candidates in Gabonese children.","author":"B Lell","year":"2007"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1056\/NEJMoa0807773","article-title":"Safety and immunogenicity of RTS,S\/AS02D malaria vaccine in infants.","volume":"359","author":"S Abdulla","year":"2008","journal-title":"NEJM"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1056\/NEJMoa0807381","article-title":"Efficacy of RTS,S\/AS01E vaccine against malaria in children 5 to 17 months of age.","volume":"359","author":"P Bejon","year":"2008","journal-title":"NEJM"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.vaccine.2003.09.008","article-title":"The Brighton Collaboration Seizure Working Group. Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation.","volume":"22","author":"J Bonhoeffer","year":"2004","journal-title":"Vaccine"},{"key":"ref12","article-title":"State of the art of vaccine research and development: Initiative for vaccine research World Health Organization, January 2005.","year":"2005"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(01)06957-4","article-title":"Efficacy of RTS,S\/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in the Gambia: a randomized trial.","volume":"358","author":"KA Bojang","year":"2001","journal-title":"The Lancet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.1016\/j.vaccine.2007.05.005","article-title":"RTS,S malaria vaccine evaluation group. a phase IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S\/AS02A in malaria-na\u00efve adults.","volume":"25","author":"KE Kester","year":"2007","journal-title":"Vaccine"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"865","DOI":"10.4269\/ajtmh.1999.61.865","article-title":"A phase I safety and immunogenicity trial with the candidate malaria vaccine, RTS,S\/SABAS2, in semi-immune adults in The Gambia.","volume":"61","author":"JF Doherty","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"166","DOI":"10.4269\/ajtmh.2006.75.166","article-title":"Phase 1 safety and immunogenicity trial of malaria vaccine RTS,S\/AS02A in adults in a hyperendemic region of Western Kenya.","volume":"75","author":"JA Stoute","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0140-6736(04)17223-1","article-title":"Efficacy of the RTS,S\/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomized controlled trial.","volume":"364","author":"PL Alonso","year":"2004","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.vaccine.2007.11.003","article-title":"Safety of the RTS,S\/AS02A malaria vaccine in Mozambican children during a Phase IIb trial.","volume":"26","author":"J Sacarlal","year":"2008","journal-title":"Vaccine"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0140-6736(05)67669-6","article-title":"Duration of protection with RTS,S\/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial.","volume":"366","author":"PL Alonso","year":"2005","journal-title":"Lancet"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1016\/j.vaccine.2005.03.019","article-title":"Phase I safety and immunogenicity of RTS,S\/AS02A candidate malaria vaccine in Gambian children.","volume":"23 (32)","author":"K Bojang","year":"2005","journal-title":"Vaccine"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-3156.2006.01754.x","article-title":"Safety, reactogenicity and immunogenicity of the RTS,S\/AS02A candidate malaria vaccine in children aged 1 to 4 years in Mozambique.","volume":"12(1)","author":"E Macete","year":"2007","journal-title":"Trop Med Int Health"},{"key":"ref22","first-page":"185","article-title":"Changing pattern of intestinal obstruction in Accra, Ghana.","volume":"2000; 47","author":"EQ Archampong","journal-title":"Hepatogastroenterology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0264-410X(89)90046-7","article-title":"Effect of timing of hepatitis B vaccine doses on response to vaccine in Yucpa Indians.","volume":"7(2)","author":"SC Hadler","year":"1989","journal-title":"Vaccine"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/BF01646879","article-title":"Four-year experience with a recombinant vaccine.","volume":"17","author":"W Jilg","year":"1989","journal-title":"Infection"}],"updated-by":[{"DOI":"10.1371\/annotation\/23dc5ebf-15ce-4f77-9aaf-9afec78e19b5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2010,11,17]],"date-time":"2010-11-17T00:00:00Z","timestamp":1289952000000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0007302","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T22:05:53Z","timestamp":1710626753000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0007302"}},"subtitle":[],"editor":[{"given":"Denise L.","family":"Doolan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,10,2]]},"references-count":24,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2009,10,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0007302","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,2]]}}}